The efficacy of omalizumab treatment in chronic spontaneous urticaria is associated with basophil phenotypes
Kirti Johal, Kristin Chichester, E Oliver, Kelly Devine, Anja P. Bieneman, John T. Schroeder, Donald W. MacGlashan, Sarbjit S. Saini
Topics & Concepts
OmalizumabBasophilMedicineChronic urticariaPhenotypeBasophil activationImmunologyDermatologyImmunoglobulin EAntibodyBiologyGeneticsGeneUrticaria and Related ConditionsCoagulation, Bradykinin, Polyphosphates, and AngioedemaDrug-Induced Adverse Reactions